Monday, January 16, 2017 4:48:29 PM
The guidelines indicate that a Type B meeting will be scheduled within 60 days from receipt of request, not 60 days from granting the meeting. Unfortunately, we don't know when the meeting was requested. The updated results were announced on November 29, so obviously the request was not made before that date. The announcement that a meeting had been scheduled was on January 4. So the literal timeframe would be between those two dates. Realistically, a request was not made immediately on November 29--one would have to assume that there was time needed to prepare the request. On the other hand, it does not seem plausible that the request was made after the 1st of the year--FDA would need time to evaluate the request. So, I'm guessing that the request was made sometime in the 2nd and 3rd weeks of December (12-23). If this is the case, the meeting (based on the 60 day timeframe) should take place between February 9 and February 23. Of course nothing states that the time has to be 60 days, only that it must be within 60 days. So the meeting certainly could occur before February 9. I have seen some opinion that it will be on February 1 which I certainly hope is true.
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM